Document Title
ACP comment letter to Speaker Pelosi regarding the release of H.R. 3, the Lower Drug Costs Now Act
Synopsis
ACP comment letter to Speaker Pelosi regarding the release of H.R. 3, the Lower Drug Costs Now Act.
Author
Robin Chichester
Keywords
Speaker Pelosi, prescription drugs, prescription drug costs, Medicare, Medicare Part D, Medicare Part B, drug price negotiation, Average International Market (AIM) price, drug inflation rebates, out-of-pocket costs for prescription drugs, cap on Medicare Part D expenses, The Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act (S. 1209), The Prescription Drug STAR Act (H.R. 2113), the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 (H.R. 965/S. 340)
Creation Date
Modified Date
Pages
4
Document Adobe Metadata
{"Author":"Robin Chichester","CreationDate":"2019-09-25T15:05:03-04:00","Creator":"Microsoft\u00ae Word 2016","Keywords":"Speaker Pelosi, prescription drugs, prescription drug costs, Medicare, Medicare Part D, Medicare Part B, drug price negotiation, Average International Market (AIM) price, drug inflation rebates, out-of-pocket costs for prescription drugs, cap on Medicare Part D expenses, The Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act (S. 1209), The Prescription Drug STAR Act (H.R. 2113), the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 (H.R. 965\/S. 340) ","ModDate":"2019-09-26T09:34:11-04:00","Producer":"Microsoft\u00ae Word 2016","Title":"ACP comment letter to Speaker Pelosi regarding the release of H.R. 3, the Lower Drug Costs Now Act","Pages":4}
Document Type Year
2019